DEERFIELD MANAGEMENT COMPANY, L.P.

Holdings History for Larimar Therapeutics, Inc. - Common Stock, par value $0.01 per share (LRMR)

Symbol: LRMR on Nasdaq
Investment type: Equity / Common Stock, par value $0.01 per share
Latest Disclosed Shares Owned: 35,667,474 shares
Security Ownership %: 34%

Shares, Excluding Options vs Price

Value, Excluding Options

Deerfield Management Company, L.P. ownership in Larimar Therapeutics, Inc. Common Stock, par value $0.01 per share (LRMR)

02 Mar 2026 - Deerfield Management Company, L.P. has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 35,667,474 shares of Larimar Therapeutics, Inc. Common Stock, par value $0.01 per share (LRMR). This represents 34% ownership of the company. In their previous filing dated 31 Jul 2025, DEERFIELD MANAGEMENT COMPANY, L.P. had reported owning 30,667,474 shares, indicating an increase of +16%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Deerfield Management Company, L.P.	34%	-3.9%	$123,052,785	35,667,474	+5,000,000	+16%	$3.45	13D/A	27 Feb 2026	02 Mar 2026, 19:46
Deerfield Management Company, L.P.	36%		$106,722,810	30,667,474			$3.48	13D/A	31 Jul 2025	31 Jul 2025, 18:26

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	1.5%	0%	$116,612,571	30,606,974	0		$3.81	Q4 2025
30 Sep 2025	1.5%	+0.46%	$98,860,526	30,606,974	+9,375,000	+44%	$3.23	Q3 2025
30 Jun 2025	1.1%	0%	$61,360,405	21,231,974	0		$2.89	Q2 2025
31 Mar 2025	0.9%	0%	$45,648,744	21,231,974	0		$2.15	Q1 2025
31 Dec 2024	1.6%	0%	$82,167,739	21,231,974	0		$3.87	Q4 2024
30 Sep 2024	2.1%	0%	$139,069,430	21,231,974	0		$6.55	Q3 2024
30 Jun 2024	2.6%	0%	$153,931,812	21,231,974	0		$7.25	Q2 2024
31 Mar 2024	2.8%	+0.57%	$161,150,683	21,231,974	+4,290,617	+25%	$7.59	Q1 2024
31 Dec 2023	1.4%	0%	$77,083,174	16,941,357	0		$4.55	Q4 2023
30 Sep 2023	1.5%	0%	$66,918,360	16,941,357	0		$3.95	Q3 2023
30 Jun 2023	1.1%	0%	$53,026,447	16,941,357	0		$3.13	Q2 2023
31 Mar 2023	1.7%	0%	$76,744,347	16,941,357	0		$4.53	Q1 2023
31 Dec 2022	1.4%	0%	$69,967,804	16,941,357	0		$4.13	Q4 2022
30 Sep 2022	1.1%	+0.71%	$54,212,000	16,941,357	+11,111,108	+191%	$3.20	Q3 2022
30 Jun 2022	0.24%	0%	$11,427,000	5,830,249	0		$1.96	Q2 2022
31 Mar 2022	0.53%	0%	$23,613,000	5,830,249	0		$4.05	Q1 2022
31 Dec 2021	1.3%	0%	$62,908,000	5,830,249	0		$10.79	Q4 2021
30 Sep 2021	1.3%	0%	$67,223,000	5,830,249	0		$11.53	Q3 2021
30 Jun 2021	1%	+0.12%	$57,253,000	5,830,249	+685,710	+13%	$9.82	Q2 2021
31 Mar 2021	1.6%	0%	$75,162,000	5,144,539	0		$14.61	Q1 2021
31 Dec 2020	2.2%	0%	$110,145,000	5,144,539	0		$21.41	Q4 2020
30 Sep 2020	1.9%	0%	$78,043,000	5,144,539	0		$15.17	Q3 2020
30 Jun 2020	1.9%	+1.9%	$66,107,000	5,144,539	+5,144,539	NEW	$12.85	Q2 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.